Views

A prescription model will help to stop new cases and alleviate the pressures faced by many women with HIV.

30% of sexual health services in rural England don’t offer this postal service

Initiatives like HIV Testing Week increase our chances of stopping new HIV transmissions by 2030.

Daniel Fluskey, our Director of Policy, Research and Influencing takes a look back over what has been achieved in 2024, and what we still need to do as we head towards 2030.

Oluwakemi Agunbiade, our Senior Research & Policy Officer, writes about how health inequalities faced by Black people with and at risk of HIV are not new – and that is the problem.

James Cole, our Senior Policy, Research and Influencing Manager, write about how disengagement in HIV care is a global issue driven by inequalities and intersecting forms of stigma and discrimination.

Daniel Fluskey, our Director of Policy, Research and Influencing, writes about how ensuring high quality, equitable, and sustainable HIV and sexual health services across the UK has to be the bedrock of public policy that aims to end HIV transmissions and support everyone to live well with HIV.

Deborah Gold writes how we’re delighted with the encouraging updates in the HIV Action Plan annual report, but must not lose sight of the challenges that still remain.

Winnie Sseruma writes that the game-changing HIV prevention drug PrEP is a vital tool to end new HIV transmissions. But a 2022 report showed that many who might benefit from PrEP were not currently able to access it, including women and those from racially minoritised communities.